Trial Profile
Oral vinorelbine and cisplatin and concurrent radiotherapy after induction chemotherapy with cisplatin-docetaxel in patients with locally advanced non-small-cell lung cancer. A multicenter phase II trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2007
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Nov 2007 Status changed from recruiting to completed.
- 08 Aug 2006 New trial record.